Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Sets New 1-Year High – Still a Buy?

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares traded. The stock had previously closed at $52.25.

Wall Street Analysts Forecast Growth

RCDTF has been the subject of several recent research reports. Royal Bank of Canada raised Recordati Industria Chimica e Farmaceutica to a “hold” rating in a research note on Monday, October 7th. Barclays raised shares of Recordati Industria Chimica e Farmaceutica to a “strong sell” rating in a research report on Tuesday, October 22nd.

Recordati Industria Chimica e Farmaceutica Stock Performance

The company has a quick ratio of 0.95, a current ratio of 1.36 and a debt-to-equity ratio of 0.73. The firm’s fifty day moving average is $52.21 and its 200-day moving average is $52.02.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.